The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Open accessAbstract
Our understanding of Alzheimer's disease pathogenesis is currently limited by difficulties in obtaining live neurons from patients and the inability to model the sporadic form of the disease. It may be possible to overcome these challenges by reprogramming primary cells from patients into induced pluripotent stem cells (iPSCs). Here we reprogrammed primary fibroblasts from two patients with familial Alzheimer's disease, both caused by a duplication of the amyloid-β precursor protein gene (APP; termed APP(Dp)), two with sporadic Alzheimer's disease (termed sAD1, sAD2) and two non-demented control individuals into iPSC lines. Neurons from differentiated cultures were purified with fluorescence-activated cell sorting and characterized. Purified cultures contained more than 90% neurons, clustered with fetal brain messenger RNA samples by microarray criteria, and could form functional synaptic contacts. Virtually all cells exhibited normal electrophysiological activity. Relative to controls, iPSC-derived, purified neurons from the two APP(Dp) patients and patient sAD2 exhibited significantly higher levels of the pathological markers amyloid-β(1-40), phospho-tau(Thr 231) and active glycogen synthase kinase-3β (aGSK-3β). Neurons from APP(Dp) and sAD2 patients also accumulated large RAB5-positive early endosomes compared to controls. Treatment of purified neurons with β-secretase inhibitors, but not γ-secretase inhibitors, caused significant reductions in phospho-Tau(Thr 231) and aGSK-3β levels. These results suggest a direct relationship between APP proteolytic processing, but not amyloid-β, in GSK-3β activation and tau phosphorylation in human neurons. Additionally, we observed that neurons with the genome of one sAD patient exhibited the phenotypes seen in familial Alzheimer's disease samples. More generally, we demonstrate that iPSC technology can be used to observe phenotypes relevant to Alzheimer's disease, even though it can take decades for overt disease to manifest in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“iPSC-derived neurons from individuals with AD exhibit increased production of Aβ42, active GSK-3β, phosphorylated tau, endosomal abnormalities, and oxidative stress (12–17)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but late-stage neuropathological features, such as formation of insoluble tau and neurodegeneration have not been reported.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of pTau in FAD neurons can be reversed by inhibition of β-secretase, the enzyme that converts APP to β-CTF indicating a direct relationship between APP processing and Tau (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, neuronal endosomal swelling has been classed as an early hallmark of Alzheimer's disease indicative of a perturbation in endosomal cargo sorting [8,9,56].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [56]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, inhibition of γ-secretase (to prevent generation of Aβ from β-CTF) did not reduce pTau, indicating that the effect of APP processing on pTau in early AD neurons is not solely mediated by extracellular Aβ (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“pThr231Tau accumulates in APP duplication (APPdp) iPSC-derived FAD neurons (Israel et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
In the citing paper
“Several studies related to neurological disease successfully reverted a disease-associated cellular phenotype in patient-derived cells by correcting the disease-associated mutation, for example in the MAPT gene106,107.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [106]
In the citing paper
“Multiple groups have characterized iPSC lines from donor cells from FAD and sAD patients, which show increased production of Aβ, particularly Aβ42, and tau hyperphosphorylation in comparison to iPSCs derived from age-matched non-demented controls [66, 82, 101, 175].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
In the citing paper
“Some iPSC lines also have evidence of additional AD-associated pathology such as increased activation of GSK3β [66], increased number of large endosomes [66], and accumulation of intraneuronal Aβ oligomers [82].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
RetractedInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
Cited by
Sorted by citations
Items 701–800 of 1,002
Grieshammer, U., & Shepard, K. A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0191 · Cited by 15
DNA Repair Mechanisms in Huntington’s Disease
Jonson, I., Ougland, R., & Larsen, E. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8409-7 · Cited by 17
Functional evaluation of genetic variation in complex human traits
Peters, D. T., & Musunuru, K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds363 · Cited by 15
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 16
Self-citationNeural Stem Cell Dysfunction in Human Brain Disorders
Liszewska, E., & Jaworski, J. (2018) · Results and problems in cell differentiation · doi:10.1007/978-3-319-93485-3_13 · Cited by 15
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer’s disease
Riemens, R. J. M., Kenis, G., & van den Beucken, T. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107318 · Cited by 16
Bartesaghi, R., Vicari, S., & Mobley, W. C. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-041521-103641 · Cited by 18
From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers
Hales, C. M., & Hu, W. T. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.776522 · Cited by 16
Iacovides, D. C., Rizki, G., Lapathitis, G., & Strati, K. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0357-5 · Cited by 18
Modeling tau pathology in human stem cell derived neurons
Wray, S. (2017) · Brain Pathology · doi:10.1111/bpa.12521 · Cited by 14
Rubio, A. D., Hamilton, L. L., Bausch, M., Jin, M., Papetti, A. V., Jiang, P., & Yelamanchili, S. V. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10181-x · Cited by 17
Future Viable Models of Psychiatry Drug Discovery in Pharma
Rizzo, S. J. S., Edgerton, J. R., Hughes, Z. A., & Brandon, N. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113475871 · Cited by 14
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Central nervous system organoids for modeling neurodegenerative diseases
Hou, P., & Kuo, H. (2022) · IUBMB Life · doi:10.1002/iub.2595 · Cited by 14
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Caldwell, A. B., Liu, Q., Zhang, C. M., Schroth, G. P., Galasko, D. R., Rynearson, K. D., Tanzi, R. E., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12553 · Cited by 16
Self-citationTowards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Área-Gómez, E., & Schon, E. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231318 · Cited by 18
Decoding molecular mechanisms: brain aging and Alzheimer’s disease
Hayat, M., Syed, R. A., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R. A., Albassam, L. A. M., Kaleem, I., Wang, X., Wang, R., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01403 · Cited by 14
Progress in Alzheimer’s disease research in the last year
Galimberti, D., & Scarpini, E. A. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6921-3 · Cited by 14
Label-free detection microarray for novel peptide ligands screening base on MS–SPRi combination
Wang, W., Zhang, D., Wei, Z., Wang, Z., Bu, X., Yang, S., Fang, Q., & Hu, Z. (2014) · Talanta · doi:10.1016/j.talanta.2014.12.012 · Cited by 14
Crook, J. M., Wallace, G. G., & Tomaskovic‐Crook, E. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1013096 · Cited by 15
Induced Pluripotent Stem Cells and Disorders of the Nervous System
Faiz, M., & Nagy, A. (2013) · The Neuroscientist · doi:10.1177/1073858413493148 · Cited by 14
Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer’s Disease
Blanchard, J., & Tsai, L. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.003 · Cited by 13
Qiu, Q., Shen, L., Jia, L., Wang, Q., Li, F., Li, Y., & Jia, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181291 · Cited by 14
Wuli, W., Tsai, S., Chiou, T., & Harn, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041327 · Cited by 16
Watanabe, H., Imaizumi, K., Cai, T., Zhou, Z., Tomita, T., & Okano, H. (2021) · eNeuro · doi:10.1523/eneuro.0500-20.2021 · Cited by 15
Matsumoto, R., Yamamoto, T., & Takahashi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910184 · Cited by 14
Supakul, S., Okano, H., & Maeda, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.768948 · Cited by 15
Lim, J. Y., Lee, J. E., Park, S. A., Park, S., Yon, J.-M., Park, J.-A., Jeun, S., Kim, S. J., Lee, H. J., Kim, S. W., et al. (2022) · Cells · doi:10.3390/cells11061029 · Cited by 15
Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2–encoded Nsp1
Wang, X., Rimal, S., Tantray, I., Geng, J., Bhurtel, S., Khaket, T. P., Li, W., Han, Z., & Lu, B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202322119 · Cited by 14
Singh, S., Srivastava, A., Srivastava, P., Dhuriya, Y. K., Pandey, A., Kumar, D., & Rajpurohit, C. S. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00072 · Cited by 14
Induced Pluripotent Stem Cells: Global Research Trends
Negoro, T., Okura, H., & Matsuyama, A. (2017) · BioResearch open access · doi:10.1089/biores.2017.0013 · Cited by 15
Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming
Meng, S., Chanda, P. K., Thandavarayan, R. A., & Cooke, J. P. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7364 · Cited by 16
Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
Lee, D., Choi, Y. H., Seo, J., Kim, J. K., & Lee, S. B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101069 · Cited by 14
Chen, S.-D., Li, H., Cui, M., Dong, Q., & Yu, J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767579 · Cited by 15
Martins, S., Müller‐Schiffmann, A., Erichsen, L., Bohndorf, M., Wruck, W., Sleegers, K., Broeckhoven, C. V., Korth, C., & Adjaye, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124516 · Cited by 14
Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
Romanazzo, S., Lin, K., Srivastava, P., & Kilian, K. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.007 · Cited by 15
Kazmerova, Z., Žilka, N., Cente, M., Neradil, P., Žilková, M., & Novák, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130572 · Cited by 14
Plurigon: three dimensional visualization and classification of high-dimensionality data
Martin, B., Chen, H., Daimon, C. M., Chadwick, W., Siddiqui, S., & Maudsley, S. R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00190 · Cited by 14
Current concepts in Alzheimer’s Disease: molecules, models and translational perspectives
Rutten, B. P. F., & Steinbusch, H. W. M. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-33 · Cited by 15
Cusulin, C., Wells, I., Badillo, S., Duran-Pacheco, G. C., Baumann, K., & Patsch, C. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103392 · Cited by 13
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
Apolipoprotein E intersects with amyloid-β within neurons
Konings, S. C., Nyberg, E., Martinsson, I., Torres-Garcia, L., Klementieva, O. L., Almeida, C. G., & Gouras, G. K. (2023) · Life Science Alliance · doi:10.26508/lsa.202201887 · Cited by 12
Human fetal tissue is critical for biomedical research
Brumbaugh, J., Aguado, B. A., Lysaght, T., & Goldstein, L. S. B. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.008 · Cited by 13
Self-citationTimofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy
Marinowic, D. R., Majolo, F., Sebben, A. D., da Silva, V. D., Lopes, T. G., Paglioli, E., Palmini, A., Machado, D. C., & da Costa, J. C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6264 · Cited by 14
Guix, F. X., Sartório, C. L., & ILL‐Raga, G. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180089 · Cited by 13
Gutova, M., B, J. P. C. A., Adhikarla, V., Tsaturyan, L., Barish, M. E., Rockne, R. C., Moschonas, E. H., Bondi, C. O., & Kline, A. E. (2021) · Stem Cells International · doi:10.1155/2021/5549381 · Cited by 14
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
Ovchinnikov, D. A., & Wolvetang, E. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041357 · Cited by 13
Chemical Engineering of Self-Assembled Alzheimer’s Peptide on a Silanized Silicon Surface
Ammar, M., Smadja, C., Ly, G. T. P., Tandjigora, D., Vigneron, J., Etchéberry, A., Taverna, M., & Dufour‐Gergam, E. (2014) · Langmuir · doi:10.1021/la500695y · Cited by 13
Decoding transcriptional enhancers: Evolving from annotation to functional interpretation
Engel, K. L., Mackiewicz, M., Hardigan, A. A., Myers, R., & Savic, D. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.05.014 · Cited by 13
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 13
Important advances in Alzheimer’s disease from the use of induced pluripotent stem cells
Majolo, F., Marinowic, D. R., Machado, D. C., & da Costa, J. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0501-5 · Cited by 15
A Platform for Studying Neurodegeneration Mechanisms Using Genetically Encoded Biosensors
Ustyantseva, E., Medvedev, S. P., Vetchinova, A. S., Minina, J. M., Illarioshkin, S. N., & Zakian, S. M. (2019) · Biochemistry (Moscow) · doi:10.1134/s000629791903012x · Cited by 13
Differentiation of Human Embryonic Stem Cells into Neuron, Cholinergic, and Glial Cells
Hosseini, K., Lekholm, E., Ahemaiti, A., & Fredriksson, R. (2020) · Stem Cells International · doi:10.1155/2020/8827874 · Cited by 14
Ryu, W., Cohen, B. M., & Sonntag, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.697578 · Cited by 14
Inducing Cellular Aging: Enabling Neurodegeneration-in-a-Dish
Brennand, K. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.017 · Cited by 13
Shi, M., Chu, F., & Zhu, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107960 · Cited by 15
Human iPSC-derived retinal organoids develop robust Alzheimer’s disease neuropathology
James, E., Vielle, A., Cusato, K., Li, H., Lee, B., Parween, S., Howell, A., Johnson, N. R., Chial, H. J., Potter, H., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1340448 · Cited by 13
Qu, W., Lam, M., McInvale, J. J., Mares, J. A., Kwon, S. H., Humala, N., Mahajan, A., Nguyen, T. T. T., Jakubiak, K. A., Mun, J.-Y., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02755-5 · Cited by 13
Cohen, B. M., & Sonntag, K. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105238 · Cited by 13
A facilitatory role of astrocytes in axonal regeneration after acute and chronic spinal cord injury
Lu, P., Graham, L., Tran, A. N., Villarta, A., Koffler, J. Y., & Tuszynski, M. H. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114889 · Cited by 12
Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness
Qiang, L., Rao, A. N., Mostoslavsky, G., James, M. F., Comfort, N. T., Sullivan, K. A., & Baas, P. W. (2017) · Neurology · doi:10.1212/wnl.0000000000003938 · Cited by 12
Arber, C., Alatza, A., Leckey, C. A., Paterson, R. W., Zetterberg, H., & Wray, S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15315 · Cited by 13
Berryer, M. H., Rizki, G., Nathanson, A. J., Klein, J. A., Trendafilova, D., Susco, S. G., Lam, D., Messana, A., Holton, K. M., Karhohs, K. W., et al. (2023) · eLife · doi:10.7554/elife.80168 · Cited by 14
Gao, R., Xiu, W., Zhang, L., Zang, R., Yang, L., Wang, C., Wang, M., Wang, M., Li, Y., Tang, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.007 · Cited by 12
Broccoli, V., Rubio, A., Taverna, S., & Yekhlef, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215577585 · Cited by 11
Carvalho, K. M., Winter, E., & Antunes, A. M. D. S. (2015) · Intelligent Information Management · doi:10.4236/iim.2015.75022 · Cited by 13
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083774 · Cited by 15
Huang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 12
Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs
Supakul, S., Hatakeyama, Y., Leventoux, N., Itsuno, M., Numata, N., Hiramine, H., Morimoto, S., Iwata, A., Maeda, S., & Okano, H. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100101 · Cited by 11
McInvale, J. J., Canoll, P., & Hargus, G. (2024) · Brain Pathology · doi:10.1111/bpa.13231 · Cited by 11
Sollazzo, R., Puma, D. D. L., Aceto, G., Paciello, F., Colussi, C., Vita, M. G., Giuffrè, G. M., Pastore, F., Casamassa, A., Rosati, J. D., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01632-3 · Cited by 10
Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype
Wiethoff, S., Arber, C., Li, A., Wray, S., Houlden, H., & Patani, R. (2015) · Journal of Neurogenetics · doi:10.3109/01677063.2015.1053478 · Cited by 11
Doege, C. A., & Abeliovich, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.007 · Cited by 11
Genetic cell reprogramming: A new technology for basic research and applied usage
Bogomazova, A. N., Vassina, E. M., Киселев, С. Л., Lagarkova, M. A., Lebedeva, O. S., Nekrasov, E. D., Panova, A. V., Philonenko, E. S., Khomyakova, E. A., Lv, T., et al. (2015) · Russian Journal of Genetics · doi:10.1134/s102279541504002x · Cited by 11
Wesseling, H., Guest, P. C., Lago, S. G., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400008x · Cited by 11
Human-Derived Brain Models: Windows into Neuropsychiatric Disorders and Drug Therapies
Papariello, A. R., & Litwa, K. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.922 · Cited by 11
Stem cell therapy in neurological disorders: promises and concerns
Hachimi-Idrissi, S. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00055 · Cited by 11
Direct reprogramming of induced neural progenitors: a new promising strategy for AD treatment
Lai, S., Zhang, M., Xu, D., Zhang, Y., Qiu, L., Tian, C., & Zheng, J. C. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0028-y · Cited by 11
Koppensteiner, P., Boehm, S., & Arancio, O. (2014) · Cellular Reprogramming · doi:10.1089/cell.2014.0054 · Cited by 11
Tian, Z., Guo, F., Biswas, S., & Deng, W. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040594 · Cited by 11
Dai, S., Li, R., Long, Y., Titus, S., Zhao, J., Huang, R., Xia, M., & Zheng, W. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116670068 · Cited by 11
Investigating pediatric disorders with induced pluripotent stem cells
Durbin, M. D., Cadar, A. G., Chun, Y. W., & Hong, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0064-2 · Cited by 11
Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models
Kaindl, J., & Winner, B. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_111 · Cited by 12
Eglen, R. M., & Reisine, T. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318803277 · Cited by 11
Phillips, J. K., Sherman, S. A., Cotton, K. Y., Heddleston, J. M., Taylor, A. B., & Finan, J. D. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.12.005 · Cited by 11
Giudice, M. L., Mihalik, B., Turi, Z., Dinnyés, A., & Kobolák, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190602 · Cited by 11
PICALM regulates cathepsin D processing and lysosomal function
Hattersley, K. J., Carosi, J. M., Hein, L. K., Bensalem, J., & Sargeant, T. J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.024 · Cited by 10
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Khezri, M. R., & Ghasemnejad‐Berenji, M. (2023) · npj Aging · doi:10.1038/s41514-023-00104-6 · Cited by 11
Culibrk, R. A., Ebbert, K. A., Yeisley, D. J., Chen, R., Qureshi, F. A., Hahn, J., & Hahn, M. S. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230600 · Cited by 10
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 12
Takeuchi, L. E., Kalia, L. V., & Simmons, C. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106864 · Cited by 11
Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer’s disease
Culley, G. R., Henriques, A., Hardy, D., Wojcinski, A., Chabert, A., Waly, B. E., Poindron, P., & Callizot, N. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1569181 · Cited by 11
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
Zeng, P.-M., Sun, X.-Y., Li, Y., Wu, W.-D., Huang, J., Cao, D.-D., Qian, P.-J., Ju, X.-C., & Luo, Z. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102601 · Cited by 14
Stem cells in cardiovascular diseases: turning bad days into good ones
Barreto, M. S. O., Saldanha‐Araújo, F., Goes, A. M., Costa, F. F., & Carvalho, J. L. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.07.012 · Cited by 10
Pathological Human Astroglia in Alzheimer's Disease: Opening New Horizons with Stem Cell Technology
Mohamet, L., Jones, V. C., Dayanithi, G., & Verkhratsky, A. (2018) · Future Neurology · doi:10.2217/fnl-2017-0029 · Cited by 11
Li, Y., Terstappen, G. C., & Zhang, W. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_363 · Cited by 10
Hwang, J. J., Choi, J., Rim, Y. A., Nam, Y., & Ju, J. H. (2021) · Cells · doi:10.3390/cells10113032 · Cited by 10
Metadata
- Authors
- Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., Carson, C. T., Laurent, L. C., Marsala, M., Gage, F. H., Remes, A. M., Koo, E. H., & Goldstein, L. S. B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Scripps Research Institute (US)
- BD Biosciences (United States) (US)
- University of Oulu (FI)
- Corresponding author
- Goldstein, Lawrence S. B.
- ORCID
- Venue
- Nature
- Published
- 2012-01-25
- Volume
- 482
- Issue
- 7384
- Pages
- 216-220
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3338985
- OpenAlex
- W2088714934
- Cited by
- 1,253
- References
- 37
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 73 · 2023: 61 · 2022: 100 · 2021: 73 · 2020: 105 · 2019: 86 · 2018: 87 · 2017: 76 · 2016: 108 · 2015: 105 · 2014: 106 · 2013: 95 · 2012: 74
- FWCI
- 81.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- (No Title)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (P50AG005131)
- National Institute of General Medical Sciences (T32GM008666)
- National Institute of Neurological Disorders and Stroke (P30NS047101, RC1NS068705)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001259)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, induced pluripotent stem cells, familial Alzheimer's disease, sporadic Alzheimer's disease, amyloid-beta secretion, gamma-secretase inhibitors, beta-secretase inhibitors, phosphorylated tau, glycogen synthase kinase-3β, APP proteolytic processing, iPSC-derived neurons, patient-derived fibroblasts
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Astrocytes, Cells, Cultured, Enzyme Activation, Female, Fibroblasts, Humans, Male, Middle Aged, Models, Biological, Neurons, Peptide Fragments, Phosphoproteins, Phosphorylation, Protease Inhibitors, Endosomes, Biomarkers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Synapsins, tau Proteins, Coculture Techniques, Glycogen Synthase Kinase 3, Amyloid Precursor Protein Secretases, Induced Pluripotent Stem Cells, Proteolysis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
